Mei Pharma, INC. (LITS) SEC Filings — 2024
17 SEC filings for Mei Pharma, INC. (LITS) in 2024.
Filings
- MEI Pharma Executive Compensation Details Revealed — DEF 14A · Dec 20, 2024
- MEI Pharma Files 8-K on Shareholder Nominations — 8-K · Nov 25, 2024
- MEI Pharma Files 8-K on Financials — 8-K · Nov 14, 2024
- MEI Pharma Q1 2025 Update: Focus on Operations — 10-Q · Nov 12, 2024
- MEI Pharma Acquired by PharmaEssentia — 8-K · Oct 25, 2024
- MEI Pharma Files 2024 10-K, Details Partnerships and Assets — 10-K · Sep 19, 2024
- MEI Pharma Announces Board Changes and New CMO — 8-K · Aug 2, 2024
- MEI Pharma Files 8-K: Regulation FD & Exhibits — 8-K · Jul 30, 2024
- PharmaEssentia to Acquire MEI Pharma for $416M — 8-K · Jul 22, 2024
- MEI Pharma Appoints New Chief Medical Officer — 8-K · Jun 25, 2024
- MEI Pharma Files 8-K for Disclosure and Exhibits — 8-K · May 21, 2024
- MEI Pharma, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 9, 2024
- MEI Pharma Files Standard 8-K Report — 8-K · Feb 21, 2024
- Mei Pharma, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Mei Pharma, INC. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- MEI Pharma, Inc. Files 10-Q for Period Ending December 31, 2023 — 10-Q · Feb 13, 2024
- MEI Pharma 8-K: Officer/Director Changes, Comp Arrangements — 8-K · Jan 17, 2024